by Five Rivers Rx | Feb 12, 2020 | Five Rivers, Industry News
Over two years in the making, the light at the end of the tunnel might finally be in sight – the Drug Enforcement Administration’s (DEA) has issued a Notice for Proposed Rule making as an update to the infamous definition of a “suspicious order.” In Fall...
by Five Rivers Rx | May 19, 2019 | Five Rivers
PHILADELPHIA — Sumeet Singh, President & Founder of Five Rivers RX, was among the eighteenth cohort of 30 graduates who recently completed the Goldman Sachs 10,000 Small Businesses-Greater Philadelphia program. Five Rivers RX is a company dedicated to being a...
by Five Rivers Rx | Jan 30, 2019 | Five Rivers, VAWD
We are excited to announce that our client, Teva Pharmaceuticals, was awarded VAWD® Reaccreditation at both of their distribution centers, in North Wales and New Britain (Chalfont), Pennsylvania! Over the past 11 months, Samuel Smith, Esq. led efforts in working with...
by Five Rivers Rx | Dec 20, 2018 | Five Rivers
Looking Back It is everyone’s favorite time of year! With the holiday season in full swing, we like to take a look at the year(s) past and what is to come! Accomplishments 2018 was a great year for outside recognition of our company! We were honored/excited to: be...
by Five Rivers Rx | Oct 18, 2018 | Five Rivers
Pharmaceutical compliance partnership allows manufacturers and distributors to more easily meet and exceed DEA due diligence requirements. Penn Valley, PA — October 5, 2018 — Five Rivers RX, a leading provider of compliance services to the pharmaceutical supply...
by Five Rivers Rx | Aug 16, 2018 | Five Rivers, Optum Rx, VAWD
1. Are there states other than NY that have legislation that makes it difficult for Optum to enforce VAWD requirement? At this time, we have only verified that New York State has a bill in place to limit the control a PBM has over reimbursements in regards to the...
